zoledronic acid has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Le, AD; Lee, S; Naji, A; Xu, Q; Yu, W; Zhang, Q | 1 |
| Cong, J; Cui, M; Sun, J; Wang, LJ; Yu, LZ; Zhang, N | 1 |
2 other study(ies) available for zoledronic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Bisphosphonate Induces Osteonecrosis of the Jaw in Diabetic Mice via NLRP3/Caspase-1-Dependent IL-1β Mechanism.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Carrier Proteins; Caspase 1; Cell Line; Diabetes Mellitus, Experimental; Diphosphonates; Gene Expression Regulation; Humans; Imidazoles; Immunohistochemistry; Inflammasomes; Interleukin-1beta; Macrophages; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species; Temperature; Wound Healing; X-Ray Microtomography; Zoledronic Acid | 2015 |
Zoledronic Acid Improves Bone Quality in the Streptozotocin-Induced Diabetes Rat through Affecting the Expression of the Osteoblast-Regulating Transcription Factors.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Morphogenetic Protein 2; Carrier Proteins; Core Binding Factor alpha Subunits; Diabetes Mellitus, Experimental; Female; Rats; Rats, Wistar; Transcription Factors; Zoledronic Acid | 2019 |